Drug Modeling Software Market Scope And Analysis

  • Report Code : TIPRE00013619
  • Category : Technology, Media and Telecommunications
  • No. of Pages : 150
Buy Now

Drug Modelling Software Market Growth and Scope - 2031

Buy Now

Drug Modelling Software Market Report Drug Modelling Software Market Size and Share Drug Modelling Software Market Scope and Analysis

Drug Modelling Software Market Report Scope

Report Attribute Details
Market size in 2023 US$ 7.96 Billion
Market Size by 2031 US$ 17.14 Billion
Global CAGR (2023 - 2031) 10.1%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product Type
  • Database
  • Software
By Application
  • Drug Discovery and Development
  • Computational Physiological Medicine
  • Disease Modelling
  • Medical Imaging
  • Predictive Analysis of Drug Targets
  • Simulation Software
  • Cellular Simulation
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Crown Bioscience Inc
  • Chemical Computing Group Ulc
  • Nimbus Therapeutics
  • Schr dinger Inc
  • Dassault Syst mes
  • Genedata Ag
  • Biognos Ab
  • Compugen Ltd
  • Acellera ltd
  • Leadscope Inc
    		•